Showing 9,261 - 9,280 results of 34,782 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 0.93s Refine Results
  1. 9261
  2. 9262
  3. 9263
  4. 9264

    Effect of BNN27 treatment on motor neuron survival in male and female mice. by Kelly E. Glajch (3204465)

    Published 2016
    “…BNN27 treatment (10 mg/kg or 50 mg/kg) had no effect on motor neuron counts in male (a; p>0.05, Kruskal-Wallis test) or female (b; p>0.05, Kruskal-Wallis test) mice. …”
  5. 9265

    Methodology. by Scott John (228011)

    Published 2024
    “…Upon binding of lactate YFP and CFP move farther apart, the intensity of YFP fluorescence decreases while that of CFP increases. This leads to a decrease in the YFP/CFP FRET ratio. …”
  6. 9266

    Effect of BNN27 treatment on neuromuscular junction integrity in male and female mice. by Kelly E. Glajch (3204465)

    Published 2016
    “…Tg vehicle-treated mice showed a decrease in the relative overlap compared to Wt vehicle-treated males (p = 0.0005, Mann-Whitney <i>U</i> test) and females (p = 0.0018, Mann-Whitney <i>U</i> test). …”
  7. 9267

    Caffeine reduces oxidative stress to protect against hyperoxia-induced lung injury via the adenosine A2A receptor/cAMP/PKA/Src/ERK1/2/p38MAPK pathway by Xijuan Wang (14103749)

    Published 2022
    “…The cyclic adenosine monophosphate (cAMP), protein kinase A (PKA) mRNA, A2AR mRNA and the protein levels of A2AR, phospho-Src, phospho-ERK1/2, phospho-P38 and cleaved caspase-3 were decreased in the caffeine and antagonist groups compared with that in the hyperoxia group. …”
  8. 9268

    Potential corner case cautions regarding publicly available implementations of the National Cancer Institute’s nonwear/wear classification algorithm for accelerometer data by Hyatt E. Moore IV (536880)

    Published 2018
    “…The number of participants with valid days, defined as 10 or more hours classified as wear time in a 24-hour day, increased while the mean counts-per-minute (CPM) decreased as the threshold for excluding non-wear was reduced from the allowed 4,000 counts in an hour. …”
  9. 9269

    Transgenerational hormetic effects of sublethal dose of flupyradifurone on the green peach aphid, <i>Myzus persicae</i> (Sulzer) (Hemiptera: Aphididae) by Qiuling Tang (495407)

    Published 2019
    “…<i>persicae</i> with a 48 h LC<sub>50</sub> of 8.491 mg/L. Using the age-stage two-sex life table approach, we assessed the effects of LC<sub>25</sub> of flupyradifurone on adult <i>M</i>. …”
  10. 9270
  11. 9271
  12. 9272
  13. 9273

    Effect of BNN27 treatment on paw grip endurance (PaGE) and rotarod in male and female mice. by Kelly E. Glajch (3204465)

    Published 2016
    “…<p>Male Tg vehicle-treated mice demonstrated a significant decrease in time spent on the PaGE test (a, left) at p95 (p = 0.0023, Mann-Whitney <i>U</i> test), p115 (p = 0.0003, Mann-Whitney <i>U</i> test), and p135 (p = 0.0385, Mann-Whitney <i>U</i> test) and the rotarod test (b, left) at p55 (p = 0.0089, Mann-Whitney <i>U</i> test), p95 (p = 0.0192, Mann-Whitney <i>U</i> test), and p135 (p = 0.0152, Mann-Whitney <i>U</i> test) relative to Wt vehicle-treated mice. …”
  14. 9274

    Effect of BNN27 treatment on body weight and neurological score in male and female mice. by Kelly E. Glajch (3204465)

    Published 2016
    “…<p>Tg vehicle-treated mice (males and females combined) exhibited a significant decrease in percent weight relative to baseline levels (a, left) at p105 (p = 0.0188, Mann-Whitney <i>U</i> test), p115 (p = 0.0025, Mann-Whitney <i>U</i> test), p125 (p<0.0001, Mann-Whitney <i>U</i> test), p135 (p<0.0001, Mann-Whitney <i>U</i> test), and p145 (p<0.0001, Mann-Whitney <i>U</i> test) compared to Wt vehicle-treated mice. …”
  15. 9275
  16. 9276
  17. 9277

    Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension by Wei-Hua Liu (4751559)

    Published 2018
    “…The effects of simvastatin were mediated by inhibition of RhoA/ROCK1. Simvastatin decreased RhoA/ROCK1 overexpression by inhibition of mevalonate, FPP, and GGPP synthesis.…”
  18. 9278
  19. 9279
  20. 9280